Connor Clark & Lunn Investment Management Ltd. bought a new position in Plexus Corp. (NASDAQ:PLXS – Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 118,917 shares of the technology company’s stock, valued at approximately $35,755,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.44% of Plexus at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in PLXS. BlackRock Inc. acquired a new stake in shares of Plexus during the 2nd quarter valued at approximately $1,311,631,000. Dimensional Fund Advisors LP increased its stake in Plexus by 0.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,373,457 shares of the technology company’s stock valued at $201,903,000 after purchasing an additional 7,051 shares during the last quarter. State Street Corp raised its holdings in shares of Plexus by 2.3% during the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock worth $143,361,000 after purchasing an additional 24,115 shares during the period. Geode Capital Management LLC raised its holdings in shares of Plexus by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 672,614 shares of the technology company’s stock worth $98,890,000 after purchasing an additional 4,054 shares during the period. Finally, Fuller & Thaler Asset Management Inc. lifted its position in shares of Plexus by 5.8% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 446,705 shares of the technology company’s stock worth $65,666,000 after buying an additional 24,441 shares during the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.
Insider Buying and Selling at Plexus
In related news, CEO Todd P. Kelsey sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $250.98, for a total value of $376,470.00. Following the sale, the chief executive officer directly owned 65,888 shares in the company, valued at $16,536,570.24. This trade represents a 2.23% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael J. Running sold 510 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $272.17, for a total value of $138,806.70. Following the completion of the sale, the insider owned 665 shares in the company, valued at approximately $180,993.05. This represents a 43.40% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 9,510 shares of company stock worth $2,622,497. 1.78% of the stock is owned by company insiders.
Plexus Stock Down 1.1%
Plexus (NASDAQ:PLXS – Get Free Report) last released its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. The business had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The company’s revenue for the quarter was up 28.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, equities analysts expect that Plexus Corp. will post 7.11 earnings per share for the current year.
Analyst Ratings Changes
PLXS has been the subject of a number of recent research reports. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective for the company in a research report on Friday, July 31st. Zacks Research raised shares of Plexus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Stifel Nicolaus lifted their target price on Plexus from $280.00 to $330.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Weiss Ratings lowered Plexus from a “buy (b)” rating to a “buy (b-)” rating in a report on Tuesday, August 11th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $310.00 price target on shares of Plexus in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $273.00.
Check Out Our Latest Stock Report on PLXS
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading
- Five stocks we like better than Plexus
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
